Business Week Ranks Renal Care Group Among ``100 Hot Growth Companies'' for 2001.

Business Editors & Health/Medical Writers

NASHVILLE, Tenn.--(BW HealthWire)--June 7, 2001

Renal Care Group, Inc. (Nasdaq/NM:RCGI) today announced that it has been included in the annual listing by Business Week of the "100 Hot Growth Companies" for 2001. This is the first time Renal Care Group has been selected to be included in the listing, which is based on a survey of approximately 10,000 public U.S. corporations. The selections are based on each company's performance over a three-year period measured by a combination of sales growth, earnings growth and return on invested capital. Renal Care Group is ranked 86th on the survey based on growth over the past three years averaging 42.6% for sales and 37.1% for net income.

"We are pleased that Renal Care has received this recognition, especially considering the rigorous standards that were applied to identify companies that historically have produced solid, stable earnings growth," said R. Dirk Allison, Chief Financial Officer. "This distinction underscores the growing strength of Renal Care Group and highlights the success we have realized with our approach to growing our business. These strategies continue to drive solid results, produce a strong return on equity, and provide a foundation for future earnings growth."

Renal Care Group is a dialysis services company that provides care to patients with kidney disease. The Company currently treats approximately 17,000 patients through 209 owned outpatient dialysis facilities, in addition to providing acute dialysis services to more than 112 hospitals. Over 5,000 associates provide services across the Company's 25-state network.

Certain statements in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect management's expectations and are based upon currently available information. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of Renal Care Group to differ materially from those expressed in or implied by the forward-looking statements, including risks related to: dependence on executive officers; compliance with health care and other applicable laws; the integration of acquired companies; changes in the Medicare and Medicaid programs; risks related to EPO; payment reductions by private insurers, hospitals or managed care organizations; and changes in the health care delivery, financing or reimbursement systems. These and other factors affecting the Company are discussed in more detail in Renal Care Group's reports filed with the Securities and Exchange Commission, including without limitation Renal Care Group's annual report on Form 10-K for the year ended December 31, 2000. Copies of these filings are available from Renal Care Group upon request.